Author:
Ogbomo Adesuwa,Tsang Yuen,Kariburyo Furaha,Tsai Wan-Lun,Panjabi Sumeet
Funder
janssen scientific affairs
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Respiratory Care
Reference44 articles.
1. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J. 2016;37(1):67–119. https://doi.org/10.1093/eurheartj/ehv317.
2. National Organization for Rare Disorders. Pulmonary arterial hypertension. https://rarediseases.org/rare-diseases/pulmonary-arterial-hypertension/#:~:text=New%20cases%20are%20estimated%20to,frequency%20of%20patients%20with%20PAH. Accessed 2 Feb 2021.
3. Farber HW, Miller DP, Poms AD, et al. Five-year outcomes of patients enrolled in the REVEAL Registry. Chest. 2015;148(4):1043–54. https://doi.org/10.1378/chest.15-0300.
4. McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21(123):8–18. https://doi.org/10.1183/09059180.00008211.
5. Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021;11(1):2045894020977300. https://doi.org/10.1177/2045894020977300.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献